InMed Pharmaceuticals Inc. 8-K

What Happened

• InMed Pharmaceuticals (INM) announced financial results for the second quarter of fiscal 2026, the period ended December 31, 2025, via a news release on February 11, 2026. The company furnished the release under Regulation FD in an 8-K filed February 12, 2026.

Key Details

• Date of announcement: February 11, 2026 (news release furnished in 8-K on Feb. 12, 2026).
• Reporting period: Second quarter of fiscal 2026, ended December 31, 2025.
• Exhibits furnished (not filed): Exhibit 99.1 — news release dated Feb. 11, 2026; Exhibit 104 — cover page interactive XBRL (embedded).

Why It Matters

• This 8-K signals InMed has publicly disclosed its quarterly earnings/financial results; investors should read the furnished press release for revenue, expense, cash position, and other metrics that affect valuation and near-term outlook. Because the material was furnished under Regulation FD (and expressly "furnished, not filed"), it was broadly released to the market but carries different legal filing implications than formally filed items.